Amgen's cholesterol-lowering antibody Repatha is being launched in Europe at well below the new drug's cost in the US, raising the chance that American payers will seek hefty discounts on the drug.

In its Thousand Oaks hometown in California, it was far and away the biggest employer, with 1 in 10 of the town folk working for Amgen. It built sites throughout Europe and Asia, and became even ...

On February 13, 2025, the FDA approved Samsung Bioepis Co., Ltd.’s denosumab biosimilars, OSPOMYV™ (denosumab-dssb; 60 mg pre-filled syringe) ...

Continued strong commercial execution of the OGSIVEO launch in the U.S. with fourth quarter and full-year 2024 U.S. net ...

A new study led by researchers from Boston University Chobanian & Avedisian School of Medicine has found there is no consensus in how clinical experts interpret CGM reports from people without ...

Remarks by Vice President JD Vance and Defense Secretary Pete Hegseth are fueling concerns that the U.S. will move away from Europe and align with Moscow. By Paul Sonne Reporting from Berlin ...

European leaders will hold an emergency summit on Ukraine Monday amid growing concern that the Trump administration’s push to work with Russia to end the war has left them isolated. The ...

So it turns out that MEGA — “Make Europe Great Again” — is not just a slogan. It’s not just a wistful line on caps worn by people on my side of the pond who wish we had a Trump-like ...

Ukraine’s president has warned the days of guaranteed US support for Europe are over, as he urged the continent to band together to create a united army and foreign policy. Volodymyr Zelensky ...

Shares of Amgen Inc. AMGN advanced 1.24% to $297.93 Thursday, on what proved to be an all-around dismal trading session for ...

Ellie Cook is a Newsweek security and defense reporter based in London, U.K. Her work focuses largely on the Russia-Ukraine war, the U.S. military, weapons systems and emerging technology.

The question for European leaders now is: what can any of them do about it? A hastily organized meeting in Paris, for now short on details in terms of attendance, is a measure of their concern as ...